Precipitating Mechanisms of Falls in Preclinical Alzheimer's Disease

被引:2
|
作者
Keleman, Audrey A. [1 ]
Nicosia, Jessica y [2 ]
Bollinger, Rebecca M. [1 ]
Wisch, Julie K. [2 ]
Hassenstab, Jason [2 ,3 ]
Morris, John C. [2 ,5 ]
Ances, Beau M. [2 ,4 ,5 ]
Balota, David A. [3 ]
Stark, Susan L. [1 ,2 ]
机构
[1] Washington Univ St Louis, Program Occupat Therapy, St Louis, MO USA
[2] Washington Univ St Louis, Dept Neurol, St Louis, MO USA
[3] Washington Univ St Louis, Dept Psychol, St Louis, MO USA
[4] Washington Univ St Louis, Dept Radiol, St Louis, MO USA
[5] Washington Univ St Louis, Hope Ctr Neurol Disorders, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; cognition; falls; functional mobility; DWELLING OLDER-PEOPLE; RISK-FACTORS; DATA SET; GAIT SPEED; PERFORMANCE; VALIDATION; VERSION; HEALTH; TAU; PREDICTOR;
D O I
10.3233/ADR-230002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Individuals with Alzheimer's disease (AD) are more than twice as likely to incur a serious fall as the general population of older adults. Although AD is commonly associated with cognitive changes, impairments in other clinical measures such as strength or functional mobility (i.e., gait and balance) may precede symptomatic cognitive impairment in preclinical AD and lead to increased fall risk. Objective: To examine mechanisms (i.e., functional mobility, cognition, AD biomarkers) associated with increased falls in cognitively normal older adults. Methods: This 1-year study was part of an ongoing longitudinal cohort study. We examined the relationships among falls, clinical measures of functional mobility and cognition, and neuroimaging AD biomarkers in cognitively normal older adults. We also investigated which domain(s) best predicted fall propensity and severity through multiple regression models. Results: A total of 182 older adults were included (mean age 75 years, 53% female). A total of 227 falls were reported over the year; falls per person ranged from 0-16 with a median of 1. Measures of functional mobility were the best predictors of fall propensity and severity. Cognition and AD biomarkers were associated with each other but not with the fall outcome measures. Conclusion: These results suggest that, although subtle changes in cognition may be more closely associated with AD neuropathology, functional mobility indicators better predict falls in cognitively normal older adults. This study adds to our understanding of the mechanisms underlying falls in older adults and could lead to the development of targeted fall prevention strategies.
引用
收藏
页码:739 / 750
页数:12
相关论文
共 50 条
  • [21] Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?
    Tropea, Thomas F.
    Chen-Plotkin, Alice
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (09):
  • [22] Slowed Driving Reaction Time in Preclinical Alzheimer's Disease
    Ahmadnezhad, Pedram
    Burns, Jeffrey M.
    Akinwuntan, Abiodun E.
    Ranchet, Maud
    Kondyli, Alexandra
    Babulal, Ganesh M.
    Mahnken, Jonathan D.
    Devos, Hannes
    JOURNAL OF APPLIED GERONTOLOGY, 2025,
  • [23] Multimorbidity Is Associated with Preclinical Alzheimer's Disease Neuroimaging Biomarkers
    Mendes, Aline
    du Montcel, Sophie Tezenas
    Levy, Marcel
    Bertrand, Anne
    Habert, Marie-Odile
    Bertin, Hugo
    Dubois, Bruno
    Epelbaum, Stephane
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2018, 45 (5-6) : 272 - 281
  • [24] Longitudinal brain structural changes in preclinical Alzheimer's disease
    Pegueroles, Jordi
    Vilaplana, Eduard
    Montal, Victor
    Sampedro, Frederic
    Alcolea, Daniel
    Carmona-Iragui, Maria
    Clarimon, Jordi
    Blesa, Rafael
    Lleo, Alberto
    Fortea, Juan
    ALZHEIMERS & DEMENTIA, 2017, 13 (05) : 499 - 509
  • [25] Preclinical Evidence and Possible Mechanisms of Extracts or Compounds from Cistanches for Alzheimer's Disease
    Zhou, Xiao-Li
    Xu, Meng-Bei
    Jin, Ting-Yu
    Rong, Pei-Qing
    Zheng, Guo-Qing
    Lin, Yan
    AGING AND DISEASE, 2019, 10 (05): : 1075 - 1093
  • [26] Early diagnosis of Alzheimer's disease: the prodromal and preclinical phase
    Valls-Pedret, Cinta
    Luis Molinuevo, Jose
    Rami, Lorena
    REVISTA DE NEUROLOGIA, 2010, 51 (08) : 471 - 480
  • [27] The critical need for defining preclinical biomarkers in Alzheimer's disease
    Fiandaca, Massimo S.
    Mapstone, Mark E.
    Cheema, Amrita K.
    Federoff, Howard J.
    ALZHEIMERS & DEMENTIA, 2014, 10 (03) : S196 - S212
  • [28] A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's Disease
    Buckley, Rachel F.
    Villemagne, Victor L.
    Masters, Colin L.
    Ellis, Kathryn A.
    Rowe, Christopher C.
    Johnson, Keith
    Sperling, Reisa
    Amariglio, Rebecca
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 60 (03) : 354 - 361
  • [29] A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer’s Disease
    Rachel F. Buckley
    Victor L. Villemagne
    Colin L. Masters
    Kathryn A. Ellis
    Christopher C. Rowe
    Keith Johnson
    Reisa Sperling
    Rebecca Amariglio
    Journal of Molecular Neuroscience, 2016, 60 : 354 - 361
  • [30] Plasma phosphorylated tau 217 in preclinical Alzheimer's disease
    Jonaitis, Erin M.
    Janelidze, Shorena
    Cody, Karly A.
    Langhough, Rebecca
    Du, Lianlian
    Chin, Nathaniel A.
    Mattsson-Carlgren, Niklas
    Hogan, Kirk J.
    Christian, Bradley T.
    Betthauser, Tobey J.
    Hansson, Oskar
    Johnson, Sterling C.
    BRAIN COMMUNICATIONS, 2023, 5 (02)